Connect with us
Prague Gaming & TECH Summit 2024

Fintech

GreenStar Biosciences Announces New Provisional Patent Application

Published

on

Latest patent application combines wearable virtual reality technology with therapeutics, further strengthening the Company’s IP portfolio for the treatment of mild traumatic brain injuries (mTBI) with PTSD or PTSD alone.

Vancouver, British Columbia–(Newsfile Corp. – September 14, 2020) – GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) (“GreenStar” or the “Company“) is pleased to announce that its wholly-owned subsidiary, Eleusian Biosciences Corporation (“Eleusian“) has added another provisional patent application to the overall existing intellectual property (“IP“) portfolio of the Company. This application further expands the portfolio of proprietary psychedelic therapeutics and devices available to GreenStar and strengthens the IP portfolio for treatment of neuropsychiatric disorders with psychedelic compounds.

A new provisional patent application entitled “Facial Worn Device for Administration of Pharmaceutical Agents in Combination with Virtual and Augmented Reality Simulations” was recently filed with the United States Patent and Trademark Office for a facial worn device combining virtual reality (“VR“) glasses for delivery of programmed virtual and augmented reality simulations. This device includes a nasal delivery system for administration of pharmaceutical agents and/or fragrances at preselected dosages and times. Uses include methods and kits for alleviating unwanted memories and emotions lined with post-traumatic stress disorder (“PTSD“) or mild traumatic brain injury (“mTBI“) with PTSD.

The device provides for immersion into a multi-sensory, three-dimensional environment that can simulate various senses such as vision and hearing to guide and enhance the therapeutic effects of one or more pharmaceutical ingredients. The device may be used in a clinical setting or remotely via, for example, wifi where the dosing and VR content can be controlled from a remote distance via wireless connectivity and access to a shared database. In addition to single user applications, multiple devices can be used for group therapy and a therapist or clinician may wear a device along with a single user or group to watch the VR content along with the single user or group. PTSD and traumatic brain injury often coexist because brain injuries are often sustained in traumatic experiences.

Through the VR glasses and VR delivery system, the device would allow for the administration to an individual a psilocybin-derived agent and/or N-acetylcysteine (“NAC“) in combination with the VR therapy, providing an immersive VR involving affective media experiences. The unique abilities of VR technology allow this device to provide experiences such as guided meditations, visual and audio simulations of therapeutic journeys, guided virtual trips to different locations or timelines of past perceived traumatic experiences, and exposure therapy. Combined with nasal administration of one or more pharmaceutical agents such as a psilocybin-derived agent and/or NAC, a user of the device can be guided towards unique combinations of altered states of consciousness including, but not limited to, meditation, trance and dreamlike states, within a safe and therapeutic manner that has positive benefits for the user.

“We continue to build our IP portfolio and this latest patent application further strengthens our overall IP position as we continue to develop our technologies such as virtual reality to enhance our therapies,” said Maghsoud Dariani, CSO of GreenStar. “Virtual reality has previously been shown to have therapeutic effects, and with the addition of carefully dosed pharmaceutical agents at specific times, it is expected that these effects can be taken to a more positive and lasting level.”

“We are very pleased with how quickly Eleusian has been building its IP portfolio and executing its overall patent strategy of not only developing effective therapeutics, but also effective delivery methods,” said Tom Baird, CEO of GreenStar, “The Company believes this new device will be extremely useful in a variety of applications including, but in no way limited to, the treatment of post-traumatic stress disorder and traumatic brain injuries and in the alleviation of stress, fears and/or phobias”.

About GreenStar

GreenStar is a growth-oriented technology & services company that provides real estate, financial, management, IP & branding support to businesses. The Company operates a growing portfolio of tenant partner companies focused on developing transformational medicines and applies refined strategies to help partner companies reach their full potential. Based in Vancouver, BC, GreenStar intends to facilitate growth through acquisitions and development of additional assets, products and technologies by leveraging its capital markets, branding and operational expertise.

For further information please contact:

GreenStar Biosciences Corp.
Thomas Baird, CEO
[email protected]
Tel: (604) 834-9499

THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

Disclaimer for Forward Looking Statements

This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including statements regarding the future plans and objectives of the Company, the Company’s expectations surrounding its development of treatments for mTBI and PTSD and development of intellectual property and effective delivery methods and devices for such treatments, the Company’s expansion initiatives and pursuit of M&A activity are forward looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations are risks detailed from time to time in the filings made by the Company with securities regulations. Readers are cautioned that assumptions used in the preparation of the forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including changes to the regulatory environment; and that the current Board and management may not be able to attain the Company’s corporate goals and objectives. As a result, the Company cannot guarantee that any forward-looking statement will materialize and the reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made only as of the date of this news release and the Company does not intend to update any of the included forward-looking statements except as expressly required by applicable Canadian securities laws.

Fintech

Expressions of Interest for Director of the European Bank for Reconstruction and Development

Published

on

expressions-of-interest-for-director-of-the-european-bank-for-reconstruction-and-development

The Minister for Finance, Michael McGrath, is inviting Expressions of Interest from suitably qualified candidates to be considered as Ireland’s Director of the London-based European Bank for Reconstruction and Development (EBRD). The remunerated position of Director is an important post with a demanding workload. A full-time residential position, it is based at Bank headquarters in London.

The Minister’s nominee is expected to be appointed by the EBRD, with the agreement of Ireland’s Constituency partner countries, for a three-year term from 1 August 2024.

Minister McGrath commented:

“This is an exciting opportunity to represent Ireland (and our Constituency partners Denmark, Lithuania and Kosovo) as a Director on the Board of the European Bank for Reconstruction and Development overseeing the policy-making and governance of the Bank. The EBRD is a unique International Financial Institution supporting projects across three continents. By investing in projects which otherwise would not be fully met by the market, the EBRD promotes entrepreneurship and fosters transition towards open and sustainable market economies. I am keen to ensure our Irish representative has the ability, education, vision, and experience to make a significant contribution to the Board and brings a range of skills and diverse perspective to the deliberations of the Board.

My nominee will need high competence in economic and financial matters. Expertise can come from notable or significant achievements in the corporate or financial sector, academia, policy-focused institutions, or public service. Importantly, they will have the highest ethical standards, a strong sense of professionalism and commitment, and dedication to serving the interests of all the shareholders and be able to make themself readily available to the Board in the fulfilment of their duties.”

Expressions of interest will be accepted up to 3pm on 27th March 2024

The post Expressions of Interest for Director of the European Bank for Reconstruction and Development appeared first on HIPTHER Alerts.

Continue Reading

Fintech

Council adopts regulation on instant payments

Published

on

council-adopts-regulation-on-instant-payments

 

The Council adopted today a regulation that will make instant payments fully available in euro to consumers and businesses in the EU and in EEA countries.

The new rules will improve the strategic autonomy of the European economic and financial sector as they will help reduce any excessive reliance on third-country financial institutions and infrastructures. Improving the possibilities to mobilize cash-flows will bring benefits for citizens and companies and allow for innovative added value services.

The instant payments regulation will allow people to transfer money within ten seconds at any time of the day, including outside business hours, not only within the same country but also to another EU member state. The regulation takes into consideration particularities of non-euro area entities.

Payment service providers such as banks, which provide standard credit transfers in euro, will be required to offer the service of sending and receiving instant payments in euro. The charges that apply (if any) must not be higher than the charges that apply for standard credit transfers.

The new rules will come into force after a transition period that will be faster in the euro area and longer in the non-euro area, that needs more time to adjust.

The regulation grants access for payment and e-money institutions (PIEMIs) to payment systems, by changing the settlement finality Directive (SFD). As a result, these entities will be covered by the obligation to offer the service of sending and receiving instant credit transfers, after a transitional period. The regulation includes appropriate safeguards to ensure that the access of PIEMIs to payment systems doesn’t carry additional risk to the system.

Under the new rules, instant payment providers will need to verify that the beneficiary’s IBAN and name match in order to alert the payer to possible mistakes or fraud before a transaction is made. This requirement will apply to regular transfers too.

The regulation includes a review clause with a requirement for the Commission to present a report containing an evaluation of the development of credit charges.

Background

This initiative comes in the context of the completion of the capital markets union. The capital markets union is the EU’s initiative to create a truly single market for capital across the EU. It aims to get investment and savings flowing across all member states for the benefit of citizens, businesses, and investors.

On 26 October 2022 the Commission put forward a proposal on instant payments that amends and modernises the single euro payments area (SEPA) regulation of 2012 on standard credit transfers in euro by adding to it specific provisions for instant credit transfers in euro.

Source: European Council

The post Council adopts regulation on instant payments appeared first on HIPTHER Alerts.

Continue Reading

Fintech

FCA highlights need for enhanced competition in wholesale data markets

Published

on

fca-highlights-need-for-enhanced-competition-in-wholesale-data-markets

 

The FCA has unveiled the outcomes of its in-depth study into the wholesale data market, focusing on the sectors of credit ratings data, benchmarks, and market data vendor services.

Despite deciding against major regulatory actions due to the risk of unintended consequences that could affect the data’s availability and quality—a crucial resource for global investors—the FCA has pinpointed several areas where competition could be significantly improved.

The study’s revelations indicate that the current state of competition in these markets may lead to users incurring higher costs for data than would be the case in a more competitive environment. This concern is particularly pressing given the critical role that such data plays in supporting effective investment decisions across the financial sector.

In a move to address these findings, the FCA has proposed initiatives aimed at ensuring wholesale data is distributed under fair, reasonable, and transparent conditions. This approach forms a part of the regulator’s broader strategy to ‘repeal and replace’ assimilated EU law, reinforcing the UK’s status as a premier global financial hub fostering investment, innovation, and sustainable growth.

Sheldon Mills, the FCA’s Executive Director of Consumers and Competition, emphasised the importance of quality and accessible wholesale data for the efficiency of financial markets. “The quality and availability of wholesale data is integral to well-functioning wholesale financial markets,” Mills stated. He further clarified, “Our market study found that firms can access the data they need to make effective investment decisions. We do not believe the case has been made for significant interventions. However, we will examine ways to help support wholesale data being provided on fair, reasonable and transparent terms.”

In its commitment to fostering a competitive and fair marketplace, the FCA will continue to scrutinize allegations of anti-competitive behavior across all markets, including wholesale data markets, leveraging its powers under the Competition Act to address any such issues.

Source: Fintech Global

 

The post FCA highlights need for enhanced competition in wholesale data markets appeared first on HIPTHER Alerts.

Continue Reading

Trending